CHRS
Coherus Oncology, Inc. - Common Stock (CHRS)
$07
About Coherus Oncology, Inc. - Common Stock (CHRS)
Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan C. Herman, Doug H. Farrar and Stephen C. Glover on September 29, 2010 and is headquartered in Redwood City, CA.
Details
Daily high
$1.12
Daily low
$1.05
Price at open
$1.06
52 Week High
$2.62
52 Week Low
$0.97
Market cap
165.3M
Dividend yield
-
Volume
1.7M
Avg. volume
1.7M
P/E ratio
-1.05
Coherus Oncology, Inc. - Common Stock News
Details
Daily high
$1.12
Daily low
$1.05
Price at open
$1.06
52 Week High
$2.62
52 Week Low
$0.97
Market cap
165.3M
Dividend yield
-
Volume
1.7M
Avg. volume
1.7M
P/E ratio
-1.05